China Longevity Group Co Ltd

China Longevity Group maintains a debt-to-equity ratio of 0.91 and a current ratio of 1.61, indicating moderate leverage and acceptable short-term liquidity. The company's price-to-book ratio of 1.46 and price-to-tangible-book ratio of 1.46 suggest market valuation is in line with tangible asset values. However, net cash is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity of 5.56% and return on assets of 2.24%, both below the median for the Commodity Chemicals industry. Gross margin of 17.37% (209.32M gross profit on 1.21B revenue) and operating margin of 6.02% (72.48M operating income) are also below the industry median, indicating weaker profitability relative to peers. The company's revenue is concentrated in material products and flooring products, with no disclosed geographic diversification. This lack of segment or geographic diversification increases exposure to regional demand shifts and supply chain disruptions. Outlook data is not provided in the input, but historical revenue growth is limited to 0.67% year-over-year (1.197B actual revenue vs. 1.205B reported revenue). This suggests a flat revenue trajectory with no clear growth drivers identified in the input data. Risk assessment flags include medium liquidity risk and low dilution risk. The company's negative net cash position after debt subtraction raises concerns about its ability to fund operations without external financing. No dilution sources are identified in the input data, and the company has not issued additional shares recently. Recent events include the 2023 annual report filing, which disclosed the financial snapshot and risk assessment. No material regulatory changes or significant operational events are reported in the input data.